Don M. Bailey, Director at Lineage Cell Therapeutics, Inc. (LCTX), bought 192,310 shares at $1.04 ($200K) on 2024-02-08, disclosed to the SEC on 2024-02-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.04 | 96,155 | $100K | 50.0% |
| 2 | $1.04 | 96,155 | $100K | 50.0% |
| Total | $1.04 avg | 192,310 | $200K | 100% |
| Filing → |
| MNK | SELL | 2015-04-14 | $5.1M | — | Filing → |
| MNK | SELL | 2015-03-17 | $4.9M | — | Filing → |
| MNK | SELL | 2015-02-17 | $3.9M | — | Filing → |